Human CYP4F12 genetic polymorphism: Identification and functional characterization of seven variant allozymes

The human cytochrome CYP4F12 has been shown to be metabolically active toward inflammatory mediators and exogenous compounds such as antihistaminic drugs. We recently identified a genetic polymorphism within the promoter region, associated with a decreased level of enzyme expression. In the present study, we report the further identification of single nucleotide polymorphisms in the coding sequence of the CYP4F12 gene. A polymerase chain reaction-single strand conformational polymorphism (PCR-SSCP) analysis of DNA samples from 53 unrelated French Caucasians, allowed the identification of ten mutations, comprising seven missense mutations, 31C > T (Leu ¹¹Phe), 38C > T (Pro ¹³Leu), 47C > T (Met ¹⁶Thr), 4759G > A (Asp ⁷⁶Asn), 4801G > A (Val ⁹⁰Leu), 8896C > T (Arg ¹⁸⁸Cys) and 23545G > A (Gly ⁵²²Ser). Their functional impact toward ebastine hydroxylation was evaluated using heterologous expression in Saccharomyces cerevisiae cells of site-directed mutated cDNA variants. Five out seven variants did not exhibit any significant difference in CYP4F12 catalytic activity, whereas two variants, Val ⁹⁰Ile and Arg ¹⁸⁸Cys, displayed significant changes in their Michaelis-Menten (K _m, V _m) parameters. These data on CYP4F12 genetic polymorphism provide tools for further studies of association with pathological processes involving an inflammatory component and with variations in anti-histaminic drug response.